Q2
IFF — Q2 2026 Financial Report Analysis
IFF's continuing Taste, Health & Biosciences and Scent businesses grew sales 6% like-for-like on higher volumes, but GAAP EPS fell to $0.13 from $2.14 as last year's one-off gains lapsed and a $71M non-deductible fragrance-investigation provision hit.